CITIUS PHARMACEUTICALS INC's ticker is CTXR and the CUSIP is 17322U207. A total of 74 filers reported holding CITIUS PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.39 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2024 | $339,595 | -82.9% | 581,797 | -73.7% | 0.00% | – |
| Q1 2024 | $1,982,642 | +18.7% | 2,209,564 | +0.1% | 0.00% | – |
| Q4 2023 | $1,669,869 | +10.8% | 2,207,361 | +0.2% | 0.00% | – |
| Q3 2023 | $1,507,420 | -40.4% | 2,202,542 | +4.5% | 0.00% | – |
| Q2 2023 | $2,528,330 | +353.4% | 2,106,942 | +342.1% | 0.00% | – |
| Q1 2023 | $557,618 | -20.3% | 476,597 | -46.2% | 0.00% | – |
| Q4 2022 | $699,304 | +30.5% | 885,194 | +100.0% | 0.00% | – |
| Q3 2022 | $536,000 | +31.7% | 442,597 | 0.0% | 0.00% | – |
| Q2 2022 | $407,000 | -89.0% | 442,597 | -78.6% | 0.00% | – |
| Q1 2022 | $3,699,000 | +15.0% | 2,066,567 | -1.0% | 0.00% | – |
| Q4 2021 | $3,216,000 | -26.8% | 2,088,221 | -3.5% | 0.00% | – |
| Q3 2021 | $4,395,000 | -35.9% | 2,164,831 | +10.0% | 0.00% | – |
| Q2 2021 | $6,852,000 | – | 1,968,922 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GSA CAPITAL PARTNERS LLP | 498,783 | $394 | 0.05% |
| Inspire Advisors, LLC | 195,946 | $154,797 | 0.04% |
| Wealth Advisory Solutions, LLC | 155,850 | $123,122 | 0.03% |
| Miller Investment Management, LP | 50,000 | $39,500 | 0.01% |
| Virtu Financial LLC | 39,005 | $31 | 0.00% |
| Pasadena Private Wealth, LLC | 10,965 | $8,662 | 0.00% |
| Jump Financial, LLC | 49,251 | $38,908 | 0.00% |
| Qube Research & Technologies Ltd | 120,580 | $95,258 | 0.00% |
| TWO SIGMA SECURITIES, LLC | 61,613 | $48,674 | 0.00% |
| Kestra Advisory Services, LLC | 93,717 | $74,036 | 0.00% |